PTC Therapeutics, Inc. (PTCT)
NASDAQ · Healthcare
PTC Therapeutics, Inc. Shareholder Equity 2011–2025
PTC Therapeutics, Inc. annual shareholder equity history from 2012 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- PTC Therapeutics, Inc. shareholder equity as of December 31, 2025: -205.3M, a 81.30% decrease year-over-year.
- PTC Therapeutics, Inc. shareholder equity for 2025 were -205.3M, a 81.30% decrease from 2024.
- PTC Therapeutics, Inc. shareholder equity for 2024 were -1.10B, a 34.15% increase from 2023.
- PTC Therapeutics, Inc. shareholder equity for 2023 were -818.6M, a 135.84% increase from 2022.
- PTC Therapeutics, Inc. shareholder equity for 2022 were -347.1M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| PTC Therapeutics, Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $-205 |
| 2024 | $-1,098 |
| 2023 | $-819 |
| 2022 | $-347 |
| 2021 | $1 |
| 2020 | $482 |
| 2019 | $594 |
| 2018 | $351 |
| 2017 | $156 |
| 2016 | $120 |
| 2015 | $226 |
| 2014 | $298 |
| 2013 | $137 |
| 2012 | $-100 |
Ptc Therapeutics Inc. Shareholder Equity — FAQ
Ptc Therapeutics Inc. (PTCT) shareholder equity over the last 15 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see PTCT's shareholder equity history?
The chart and table above show Ptc Therapeutics Inc.'s shareholder equity by year and by quarter, including the growth rate.